Skip to main content
. 2016 Jun 18;14:183. doi: 10.1186/s12967-016-0926-5

Fig. 1.

Fig. 1

Deregulated lncRNAs in non end-stage HF patients. LncRNAs identified by profiling as deregulated in HF were validated by RT-qPCR in LV biopsies of 18 non end-stage ischemic dilated cardiomyopathy (HF) and 17 control subjects (CTR). Dot plots indicate fold change values of each subject with respect to controls. The horizontal bars indicate median values (*p ≤ 0.05, **p ≤ 0.01; ***p ≤ 0.001)